7445-0093 Screening compound: 2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-N-(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)acetamide

7445-0093 Screening compound: 2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-N-(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)acetamide
7445-0093 Screening compound: 2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-N-(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 7445-0093
2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-N-(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

7445-0093

Molecular Formula

C12H11N5O2S2 (C12 H11 N5 O2 S2)

Compound Name

2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-N-(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)acetamide

IUPAC name

2-[(5-methyl-134-thiadiazol-2-yl)sulfanyl]-N-(2-oxo-23-dihydro-1H-13-benzodiazol-5-yl)acetamide

SMILES

Cc1nnc(SCC(Nc(cc2)cc(N3)c2NC3=O)=O)s1

InChI

InChI=1S/C12H11N5O2S2/c1-6-16-17-12(21-6)20-5-10(18)13-7-2-3-8-9(4-7)15-11(19)14-8/h2-4H,5H2,1H3,(H,13,18)(H2,14,15,19)

InChI Key

CGDHANQXQZVSLQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD05459754

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

321.38

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.235

Distribution Coefficient, logD

1.235

Water Solubility, LogSw

-2.34

Polar Surface Area

81.515

Acid Dissociation Constant (pKa)

12.36

Base Dissociation Constant (pKb)

2.35

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

7445-0093 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Dark Chemical Matter Library (18430 compounds)

KRAS-Targeted Library (16000 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Pool
Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with 7445-0093 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 7445-0093?
Check Price and Availability of 7445-0093, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 7445-0093 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 7445-0093
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 7445-0093
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 7445-0093 available by request